Releuko

Filgrastim · Amneal Pharmaceuticals LLC
PRESCRIPTION ONLY (USA)

Releuko ingredients

Active ingredientStrength
Filgrastim300 ug/mL, 480 ug/1.6mL, 300 ug/.5mL, 480 ug/.8mL

What Releuko is used for

Releuko is a specialist medicine (leukocyte growth factor). Its approved uses are listed on the official FDA label below.

Key facts

Brand
Releuko
Generic name
Filgrastim
Made by
Amneal Pharmaceuticals LLC
Forms
Injection, Solution
Given
Intravenous, Subcutaneous
Drug class
Leukocyte Growth Factor
FDA approval
Biologic licence (BLA) BLA761082
On the US market since
2022

Official information

In India

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Releuko?

Releuko (Filgrastim) is a specialist medicine made by Amneal Pharmaceuticals LLC, approved by the US FDA.

What are the ingredients of Releuko?

Releuko contains Filgrastim (300 ug/mL, 480 ug/1.6mL, 300 ug/.5mL, 480 ug/.8mL).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.